Germex Pharmaceuticals Private Limited

Germex Pharmaceuticals Private Limited - business outsourcing in New Delhi, Delhi, India. FY 2026 financials & compliance.
CIN U24231DL2002PTC115604 Incorporated 30 May 2002 ROC Delhi HQ New Delhi, Delhi, India
Active Private Limited Company business outsourcing
Revenue · FY 2024
₹65.75 Lakh
▲ 36% YoY
Net loss · FY 2024
₹29,640
Net margin -0.5%
EBITDA · FY 2024
-₹38,968
EBITDA margin -0.6%
Authorised capital
₹2 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
24 yrs
Est. 2002
Employees · EPFO
18
Provident fund records
Directors on board
2
As per MCA filings

About Germex Pharmaceuticals Private Limited

Data last updated:

Germex Pharmaceuticals Private Limited is a private limited company based in New Delhi, Delhi, India. It operates in the HR outsourcing and talent management segment of the business process outsourcing sector. It was incorporated on 30 May 2002 and has been in existence for over 24 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL2002PTC115604. Its GSTIN is 07AABCG7029B1Z0 (Delhi).

The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Gurvinder Singh and Emendra Paul Singh.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 411 Vishal Tower 10 District Centre Janak Puri, New Delhi, Delhi, India – 110058.

As per the financials filed for FY 2024, the company reported a revenue of ₹65.75 Lakh, a growth of 36% compared to the previous year. For the same year it recorded a net loss of ₹29,640 (net margin -0.5%) and EBITDA of -₹38,968 (EBITDA margin -0.6%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 5% over five years.

The company has about 18 employees on its provident fund (EPFO) records.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231DL2002PTC115604
Registration Number 115604
Incorporation Date 30 May 2002
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Germex Pharmaceuticals Private Limited's registered office is in New Delhi, Delhi. Its e-mail address is in the company report.

  • Email
  • Registered Address
    411 Vishal Tower 10 District Centre Janak Puri, New Delhi, Delhi, India – 110058
  • Industry
    Business Outsourcing, HR Outsourcing & Talent Management

To see the full contact details of Germex Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Germex Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Germex Pharmaceuticals is support service to organizations. In detail, this covers other support services to organizations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
NSupport service to OrganizationsN7Other support services to organizations

To see the full business activity and turnover split of Germex Pharmaceuticals Private Limited, buy the company report.

Financials of Germex Pharmaceuticals Private Limited

FY 2025 filings available

Germex Pharmaceuticals Private Limited reported revenue of ₹65.75 Lakh (up 36% YoY) for FY 2024.

Revenue · FY 2024
₹65.75 Lakh ▲ 36%
Net loss · FY 2024
₹29,640 margin -0.5%
EBITDA · FY 2024
-₹38,968 margin -0.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 36%
3 years · compounded
▲ 9%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 109%
3 years · compounded
▼ 38%
5 years · compounded
▲ 5%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 36% growth in the latest year. EBITDA fell 109% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹38,968
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹29,640
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin-0.6%
Net Profit Margin-0.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Germex Pharmaceuticals Private Limited, buy the company report.

Board of directors of Germex Pharmaceuticals Private Limited

Germex Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors

Auditor

Germex Pharmaceuticals Private Limited is audited by B H S & CO for the financial year 2020.

Auditor firmFinancial yearFirm registration number
B H S & COFY 2020016889N

Shareholding

The shareholding of Germex Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2020FY 2019FY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Germex Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Germex Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Germex Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
07AABCG7029B1Z0DelhiActive01 Jul 2017

To see the full GST registrations and return filing status of Germex Pharmaceuticals Private Limited, buy the company report.

Recent activity

Germex Pharmaceuticals Private Limited has 4 board changes on record since 2003: 2 appointments and 2 cessations. The latest: Emendra Paul Singh ceased to be Additional Director on 30 Sep 2022.

AGM
Germex Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Germex Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Emendra Paul Singh ceased to be Additional Director.
Ceased
Rajendra Pratap Singh ceased to be Director.
Appointed
Emendra Paul Singh was appointed as Director.
Appointed
Gurvinder Singh was appointed as Director.
Incorporation
30 May 2002
Germex Pharmaceuticals Private Limited was registered on 30 May 2002 with Roc Delhi Ii & aged 24 years 5 months as per MCA records.

Frequently asked questions

Germex Pharmaceuticals is an active private limited company based in New Delhi, Delhi, India. The company works in HR outsourcing and talent management, within the business outsourcing industry. It was incorporated on 30 May 2002 (24+ years old) and is registered under CIN U24231DL2002PTC115604.

Germex Pharmaceuticals has 2 current directors:

The latest financial statements of Germex Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Germex Pharmaceuticals is 07AABCG7029B1Z0, registered in Delhi.

The CIN (Corporate Identification Number) of Germex Pharmaceuticals is U24231DL2002PTC115604. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Germex Pharmaceuticals was incorporated on 30 May 2002, making it 24+ years old. It is registered with the Registrar of Companies, Delhi.

Emendra Paul Singh ceased to be Additional Director on 30 Sep 2022. Rajendra Pratap Singh ceased to be Director on 28 May 2022. Emendra Paul Singh was appointed as Director on 23 May 2022. Germex Pharmaceuticals has 4 board changes on record in total.

The registered office of Germex Pharmaceuticals is at 411 Vishal Tower 10 District Centre Janak Puri, New Delhi, Delhi, India – 110058.

Germex Pharmaceuticals operates in the business outsourcing industry, in the HR outsourcing and talent management segment.

The compliance status of Germex Pharmaceuticals is compliant as of 31 July 2026. The company is actively filing with the Registrar of Companies.